Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

December 3, 2020 by Alan Khadavi

Eohilia Budesonide Oral Suspension for Eosinophilic Esophagitis

Eohilia, a budesonide oral suspension is set to be the first FDA approved treatment for eosninophilic esophagitis. Takeda pharmaceuticals is the manufacturer of the drug. Eosinophilic esophagitis (EoE) is a chronic, immune-mediated, inflammatory disease localized in the esophagus. The prevalence of EoE is rising. Approximately 1 in 2000 people in the US live with EoE.  EoE is a leading cause of dysphagia and food impaction for children and young adults.

We have extensively discussed eosinophilic esophagitis before and the treatment options available. Most allergists and GI doctors who treat EoE have been using steroid asthma inhalers in patients, instead of inhaling them, we ask patients to swallow it to coat the esophagus.  Another alternative has been getting budesonide nebulized solution and mixing with a viscous base such as sugar and the patient will swallow it after. This can be somewhat cumbersome for patients, so a cleaner and easier to use alternative of using a prescription of Eohilia a budesonide oral suspension specifically for EoE will be much better.

Past studies of budesonide oral suspension can be read here:

Budesonide Oral Suspension Significantly Improves Eosinophilic Esophagitis Histology Scoring System Results

Behaviors of patients who have EoE are chewing food excessively, eating slowly or cutting food into small pieces.

Other common adaptive behaviors are:

  • Avoidance of large meals
  • Avoidance of foods that have hard or lumpy textures
  • Poor acceptance of new foods
  • Lubricating food bites with condiments
  • Drinking with most bites of food
  • Substituting solids with blended or pureed foods
  • Avoiding social settings involving food

Patients frequently present with atopic comorbidities that can lead to delayed diagnosis of EoE. In one study, ~78% of patients had ≥1 atopic disease. A family or personal history of pre-existing allergic diseases should increase the suspicion for EoE and should be considered. Consider investigating EoE further with endoscopies and biopsies when patients present with symptoms of esophageal dysfunction along with any of the following:

  • Allergic rhinitis
  • Asthma
  • Atopic dermatitis
  • Food allergy
  • GERD

We have extensively discussed EoE in past blogs, the diagnosis, management and treatment options (present and future) are all below.

Future Eosinophilic Esophagitis Treatment Options

Eosinophilic Esophagitis (EoE) Treatment

Fasenra for Eosinophilic Esophagitis (EoE)

Other Conditions in Eosinophilic Esophagitis

Eosinophilic Esophagitis Diet

Risk Factors for Eosinophilic Esophagitis

Eosinophilic Esophagitis in Southern California

Eosinophilic Esophagitis Treatment Options

Eosinophilic Esophagitis (EoE)

Eohilia will be the first FDA approved treatment option of EoE, it is a budesonide oral suspension. The cost of Eohilia has not been released yet by Takeda, but its approval by the FDA is eminent. Check back with us later about when Eohilia is approved and the specific indications for it will be released by Takeda and the FDA.

U.S. Food and Drug Administration Accepts New Drug Application for Review, Grants Priority Review for Takeda’s TAK-721 (budesonide oral suspension) for the Treatment of Eosinophilic Esophagitis

 

Filed Under: Blog, eosinophilic esophagitis

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page